Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TTPH

Tetraphase Pharmaceuticals (TTPH) Stock Price, News & Analysis

Tetraphase Pharmaceuticals logo

About Tetraphase Pharmaceuticals Stock (NASDAQ:TTPH)

Advanced Chart

Key Stats

Today's Range
$2.18
$2.27
50-Day Range
$2.20
$2.20
52-Week Range
$0.56
$8.60
Volume
282,689 shs
Average Volume
932,542 shs
Market Capitalization
$15.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TTPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tetraphase Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TTPH Stock News Headlines

The Altcoin That Could be Poised to Benefit Most from Trump’s Return
With Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And according to Weiss Ratings analyst Juan Villaverde, a major shift is coming. Juan has nailed every major Bitcoin move since 2012—but right now, he says the biggest upside isn’t in BTC or ETH. It’s in a lesser-known altcoin he believes could become the “third pillar of crypto”… and potentially define America’s first true crypto presidency.tc pixel
TTPH_old Historical Data
10 Worst NASDAQ Biotech Stocks in the Third Quarter
See More Headlines

TTPH Stock Analysis - Frequently Asked Questions

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) announced its quarterly earnings data on Thursday, May, 7th. The biopharmaceutical company reported ($1.31) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.63) by $0.32. The biopharmaceutical company had revenue of $1.76 million for the quarter, compared to the consensus estimate of $2.45 million. Tetraphase Pharmaceuticals had a negative net margin of 798.18% and a negative trailing twelve-month return on equity of 210.86%.

Tetraphase Pharmaceuticals's stock reverse split on Friday, September 27th 2019.The 1-20 reverse split was announced on Thursday, September 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 26th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tetraphase Pharmaceuticals investors own include Alcoa (AA), Aurinia Pharmaceuticals (AUPH), GE Aerospace (GE), Bank of America (BAC), OPKO Health (OPK), Novavax (NVAX) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
5/07/2020
Today
9/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TTPH
CIK
1373707
Fax
N/A
Employees
119
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($22.85)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.08 million
Net Margins
-798.18%
Pretax Margin
N/A
Return on Equity
-210.86%
Return on Assets
-121.73%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
3.66
Quick Ratio
3.56

Sales & Book Value

Annual Sales
$7.38 million
Price / Sales
2.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.68 per share
Price / Book
0.33

Miscellaneous

Outstanding Shares
7,263,000
Free Float
N/A
Market Cap
$15.98 million
Optionable
Optionable
Beta
2.33
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:TTPH) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners